OUR PLATFORM

A test you can trust

OurPlatform1

Utilizing industry leading technology to better inform patients and physicians.

The Oro Lesion test uses next-generation sequencing (NGS) and proprietary AI-driven analysis to detect somatic mutations that signal the presence of cancer1. It fits into routine dental visits, annual physicals, or focused evaluations of persistent symptoms. Results are delivered securely to providers within days and can guide next steps.

93
%
sensitivity1
High sensitivity in genomics testing minimizes false-negative results, which helps to avoid missed cases of the disease.
99
%
specificity1
Oro Lesion accurately designates individuals without a disease as negative, reducing the likelihood of incorrectly identifying people as having the disease.

Easy to use and painless.

The Oro Lesion process is simple and stress-free. Here’s how it works:

icon-person-cross

Saliva is collected through a simple oral rinse using a provided collection kit

box

The sample is sent to a CLIA-certified lab for processing

report-icon

Our proprietary software analyzes the genomic data to detect known cancer biomarkers

 

light bule x sign
Try Oro Lesion today.
Contact us to learn more